Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography

Keyphrases

• 11C-flumazenil 16%
• Acid Type 16%
• Age Distribution 16%
• Ataxic 16%
• Basal Ganglia 33%
• Benzodiazepine Binding 16%
• Benzodiazepine Receptor 100%
• Brainstem 50%
• Cerebellar Degeneration 100%
• Cerebellum 50%
• Cerebral Hemispheres 33%
• Comparison with Data 16%
• Control Subjects 50%
• Extrapyramidal Symptoms 16%
• Multiple System Atrophy 83%
• Pharmacological Therapy 16%
• Positron Emission Tomography 100%
• Receptor Binding 100%
• Sex Distribution 16%
• Spinocerebellar Degeneration 100%
• Syndrome Type 33%
• γ-aminobutyric Acid 16%

Medicine and Dentistry

• Age Distribution 16%
• Basal Ganglia 33%
• Benzodiazepine 16%
• Benzodiazepine Receptor 100%
• Brainstem 50%
• Cerebellum 50%
• Cerebellum Degeneration 100%
• Cerebral Hemisphere 33%
• Disease 16%
• Drug Therapy 16%
• Flumazenil C 11 16%
• Olivopontocerebellar Atrophy 100%
• Positron Emission Tomography 100%
• Receptor Binding 100%
• Sex Ratio 16%
• Shy-Drager Syndrome 83%
• Thalamus 33%

Neuroscience

• Basal Ganglia 33%
• Benzodiazepine 16%
• Benzodiazepine Receptor 100%
• Brainstem 50%
• Cerebellum 50%
• Flumazenil 16%
• Multiple System Atrophy 83%
• Olivopontocerebellar Atrophy 100%
• Positron Emission Tomography 100%
• Receptor Binding 100%
• Thalamus 33%